SRIW is a private equity firm that specializes in providing equity capital.
Business Model:
Revenue: $0
Employees: 1-10
Address: 13, Avenue Destenay
City: Liege
State: liège
Zip: 4000
Country: BE
SRIW is a private equity firm that specializes in providing equity capital.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2017 | Elium | Series A | 4.8M |
10/2009 | Carmeuse Group | Venture Round | - |
4/2016 | iSTAR Medical | Series B | 11.4M |
4/2020 | ITeos Therapeutics | Series B | 0 |
3/2018 | Tessares | Venture Round | 3.7M |
1/2018 | Qualifio | Series A | 3.6M |
9/2020 | Miracor Medical | Series E | 0 |
9/2015 | Novadip Biosciences | Series A | 0 |
3/2012 | GreenWatt | Venture Round | 0 |
4/2008 | CISSOID | Series B | 1.6M |
2/2018 | Syndesi Therapeutics | Series A | 21.3M |
9/2020 | Syndesi Therapeutics | Series A | 7M |
4/2019 | Aerospacelab | Series A | 12.3M |
6/2016 | Diagenode | Venture Round | 0 |
11/2013 | iSTAR Medical | Series A | 0 |
10/2016 | Promethera Biosciences | Series C | 10.9M |
7/2015 | CluePoints | Series A | 6.6M |
6/2018 | ITeos Therapeutics | Series B | 0 |
9/2017 | e-peas | Venture Round | 4.2M |
2/2018 | Synergia Medical | Series A | 10M |
7/2020 | ExeVir Bio | Series A | 0 |
11/2017 | Ncardia | Series B | 12.4M |
9/2018 | Minoryx Therapeutics | Series B | 0 |
9/2016 | Opinum | Series A | 0 |
2/2020 | OncoDNA | Series B | 0 |
3/2016 | Opinum | Series A | 421.6k |
10/2015 | Opinum | Seed Round | 544.5k |
9/2017 | Pharmasimple | Post-IPO Equity | 6M |
10/2022 | Univercells | Series D | 0 |
9/2022 | I-care Group | Funding Round | 49M |
4/2018 | Invineo | Venture Round | 2.7M |
10/2016 | Bodair | Venture Round | - |
8/2007 | Celyad | Series A | - |
11/2016 | IONICS | Venture Round | - |
6/2014 | IBA | Venture Round | 27.4M |
9/2021 | Sortlist | Series B | 0 |
2/2013 | Icarus | Venture Round | - |
6/2017 | Tconcept | Venture Round | 11.2M |
6/2018 | Haulogy | Venture Round | 3.5M |
10/2007 | Vincent Logistics | Series B | 1.4M |
8/2001 | Quality Assistance | Venture Round | - |
2/2022 | Aerospacelab | Series B | 0 |
1/2015 | ChanvrEco | Series A | 260k |
5/2014 | Odoo | Series B | 10M |
7/2021 | Vertuoza | Seed Round | 1.4M |
3/2018 | Air Belgium | Venture Round | 24.6M |
7/2016 | Nyxoah | Series B | 19.9M |
6/2023 | Santero Therapeutics | Series A | 0 |
5/2018 | Epic Therapeutics | Seed Round | 8.4M |
4/2005 | Aseptic Technologies | Venture Round | - |
9/2017 | Dim3 | Venture Round | 4.7M |
2/2018 | ZenTech | Venture Round | - |
4/2018 | Ecophos | Venture Round | - |
7/2014 | Proxistore | Venture Round | 3.7M |
2/2021 | Imcyse | Series B | 25.7M |
12/2005 | Advanced Biological Laboratories (ABL) | Venture Round | - |
9/2009 | IPEX Group | Venture Round | - |
11/2015 | Decube Group | Venture Round | - |
6/2016 | Scidus | Venture Round | - |
6/2018 | Venyo | Venture Round | - |
10/2014 | Ncardia | Series A | 5.1M |
12/2019 | Odoo | Secondary Market | 90M |
10/2022 | Intressa Vascular | Funding Round | 12M |
9/2019 | iSTAR Medical | Series C | 44.1M |
6/2019 | Imcyse | Series B | 31.4M |
11/2011 | Alysse Food | Venture Round | - |
3/2012 | Dragone | Venture Round | - |
2/2016 | TSF BE | Venture Round | - |
7/2010 | Eurogare | Venture Round | - |
10/2022 | BOTALYS | Series B | 6.6M |
10/2022 | BOTALYS | Convertible Note | 898.5k |
10/2017 | IDDI | Venture Round | - |
9/2007 | Cosucra | Venture Round | - |
6/2016 | ISSOL | Seed Round | - |
3/2014 | Fruytier Group | Venture Round | - |
9/2009 | Intopix | Venture Round | - |
5/2018 | ChromaCure | Venture Round | 19.6M |
1/2020 | BOTALYS | Series B | 5.6M |
11/2019 | EURA NOVA | Series A | 2.5M |
12/2020 | Univercells | Series C | 24.5M |
12/2021 | PDC*line Pharma | Series B | 0 |
11/2014 | Advanced Mechanical and Optical System | Venture Round | - |
10/2022 | Intressa Vascular | Grant | 6M |
1/2020 | PDC*line Pharma | Series B | 15.4M |
10/2022 | BOTALYS | Secondary Market | 246.8k |
2/2015 | Mithra Pharmaceuticals SA | Post-IPO Equity | - |
4/2008 | Euro Heat Pipes | Venture Round | - |
2/2008 | Synthetis | Venture Round | - |
1/2013 | kitozyme | Venture Round | - |
2/2010 | Promethera Biosciences | Series A | 7.3M |
12/2016 | Performance for Assets | Venture Round | - |
4/2016 | Keybate | Seed Round | 57.2k |
5/2012 | ITeos Therapeutics | Series A | 11.8M |
10/2013 | Allmat | Venture Round | - |
6/2014 | Lasea | Venture Round | - |
7/2018 | WALMAT | Venture Round | - |
10/2016 | Quality Partner | Venture Round | - |
12/2009 | XyloWatt | Venture Round | - |
12/2013 | Trendy Foods Belgium | Venture Round | - |
12/2011 | Rentel | Venture Round | - |
12/2021 | EyeD Pharma | Venture Round | 0 |
7/2012 | Spacebel | Venture Round | - |
12/2015 | Paprika SA | Venture Round | - |
12/2015 | Any-Shape | Venture Round | - |
9/2016 | Mydibel | Venture Round | - |
10/2015 | Ogeda | Series B | 17.9M |
11/2012 | Ogeda | Private Equity Round | 13M |
10/2016 | Françoise&s;s Tartes | Venture Round | - |
10/2012 | EURODV | Venture Round | - |
1/2018 | Miracor Medical | Series D | 0 |
3/2014 | Pierret | Seed Round | - |
6/2013 | Lampiris | Venture Round | 53.4M |
2/2022 | Aerospacelab | Series B | 0 |
12/2021 | EyeD Pharma | Venture Round | 0 |
12/2021 | PDC*line Pharma | Series B | 0 |
9/2021 | Sortlist | Series B | 0 |
7/2021 | Vertuoza | Seed Round | 0 |
2/2021 | Imcyse | Series B | 0 |
12/2020 | Univercells | Series C | 0 |
9/2020 | Syndesi Therapeutics | Series A | 0 |
9/2020 | Miracor Medical | Series E | 0 |
7/2020 | ExeVir Bio | Series A | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|